Skip to main content
. 2015 Dec 11;48(3):928–941. doi: 10.4143/crt.2015.275

Fig. 4.

Fig. 4.

Kaplan-Meier curves demonstrate the differences in progression-free survival and overall survival according to equivalent dose in 2 Gy fractions (EQD2) in subgroup of patients with high total lesion glycolysis of the whole tumor. (A) Progression-free survival. (B) Overall survival.